The UC San Diego Medical Center, Hillcrest is one of two medical centers of UC San Diego Health and is a teaching hospital for the University of California San Diego School of Medicine.

During the past decade, UC San Diego Medical Center - Hillcrest conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 32 clinical trials were completed, i.e. on average, 71.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 18 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UC San Diego Medical Center - Hillcrest" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Pfizer" with 22 trials sponsored, "University of California, San Diego" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "University of Michigan" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UC San Diego Medical Center - Hillcrest" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 7 trials as a collaborator, "Medical University of South Carolina" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator and "AstraZeneca" with 3 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "UC San Diego Medical Center - Hillcrest" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Advanced Malignant Solid Neoplasm" (3 trials), "Pancreatic Carcinoma" (3 trials), "Stage IV Breast Cancer AJCC v6 and v7" (3 trials) and "Stroke" (3 trials). Many other conditions were trialed in "UC San Diego Medical Center - Hillcrest" in a lesser frequency.

Most popular intervention types in "UC San Diego Medical Center - Hillcrest" are "Drug" (57 trials), "Other" (29 trials), "Biological" (17 trials), "Procedure" (15 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (10 trials), "Biospecimen Collection" (8 trials), "Placebo" (8 trials) and "Computed Tomography" (6 trials). Other intervention names were less common.

The vast majority of trials in "UC San Diego Medical Center - Hillcrest" are 65 trials for "All" genders, 7 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "UC San Diego Medical Center - Hillcrest". undefined are not yet recruiting, 18 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in UC San Diego Medical Center - Hillcrest, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in UC San Diego Medical Center - Hillcrest, 12 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".